Dolores Schendel

Chief Tech/Sci/R&D Officer at MEDIGENE AG

Health Technology

Consumer Services

Miscellaneous

Profile

Dr. Dolores J.
Schendel is a Chief Scientific Officer at MediGene AG and a Chief Executive Officer at Medigene, Inc. Dr. Schendel was previously employed as a Managing Director by Medigene Immunotherapies GmbH, a Member-Scientific Review Board by Deutsche Forschungsgemeinschaft, a Member-Scientific Review Board by European Research Council, a Member-Scientific Review Board by German Cancer Aid, and a Professor by Ludwig-Maximilians-Universität München.
She also served on the board at Institute of Molecular Immunology.
She received her doctorate degree from the University of Wisconsin.

Dolores Schendel active positions

Companies	Position	Start
MEDIGENE AG	Chief Tech/Sci/R&D Officer	01/05/2014
MediGene, Inc. MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery	Chief Executive Officer	-

All active positions of Dolores Schendel

Former positions of Dolores Schendel

Companies	Position	End
Institute of Molecular Immunology	Director/Board Member	01/01/2013
European Research Council European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars	Corporate Officer/Principal	-
German Cancer Aid	Corporate Officer/Principal	-
Deutsche Forschungsgemeinschaft Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Medigene Immunotherapies GmbH Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer	Chief Executive Officer	-

See the detail of Dolores Schendel's experience

Training of Dolores Schendel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Dolores Schendel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
MediGene AG MediGene AG BiotechnologyHealth Technology Engages in the clinical research and development of novel drugs against cancer & autoimmune diseases with focus on personalized immunotherapies	Health Technology
MediGene, Inc. MediGene, Inc. Pharmaceuticals: MajorHealth Technology Develops herpes simplex virus technologies for the treatment of tumors and for gene delivery	Health Technology
University of Wisconsin University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ludwig-Maximilians-Universität München Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
European Research Council European Research Council Investment Trusts/Mutual FundsMiscellaneous Provides funding initiative designed to support the scientists, engineers, and scholars	Miscellaneous
Deutsche Forschungsgemeinschaft Deutsche Forschungsgemeinschaft Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Institute of Molecular Immunology
Medigene Immunotherapies GmbH Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Develops immunotherapy to treat cancer	Health Technology
German Cancer Aid